nodes	percent_of_prediction	percent_of_DWPC	metapath
Butabarbital—Vomiting—Estrone—prostate cancer	0.00376	0.00492	CcSEcCtD
Butabarbital—Angioedema—Ethinyl Estradiol—prostate cancer	0.00375	0.00491	CcSEcCtD
Butabarbital—Rash—Estrone—prostate cancer	0.00373	0.00488	CcSEcCtD
Butabarbital—Dermatitis—Estrone—prostate cancer	0.00373	0.00487	CcSEcCtD
Butabarbital—Headache—Estrone—prostate cancer	0.00371	0.00484	CcSEcCtD
Butabarbital—Depressed level of consciousness—Capecitabine—prostate cancer	0.00369	0.00483	CcSEcCtD
Butabarbital—Nausea—Estramustine—prostate cancer	0.00368	0.00481	CcSEcCtD
Butabarbital—Body temperature increased—Cabazitaxel—prostate cancer	0.00366	0.00478	CcSEcCtD
Butabarbital—Dizziness—Nilutamide—prostate cancer	0.00363	0.00475	CcSEcCtD
Butabarbital—Dizziness—Flutamide—prostate cancer	0.00362	0.00473	CcSEcCtD
Butabarbital—Hypersensitivity—Degarelix—prostate cancer	0.00362	0.00473	CcSEcCtD
Butabarbital—Somnolence—Bicalutamide—prostate cancer	0.00353	0.00461	CcSEcCtD
Butabarbital—Nausea—Estrone—prostate cancer	0.00351	0.00459	CcSEcCtD
Butabarbital—Vomiting—Nilutamide—prostate cancer	0.00349	0.00457	CcSEcCtD
Butabarbital—Anxiety—Ethinyl Estradiol—prostate cancer	0.00349	0.00456	CcSEcCtD
Butabarbital—Vomiting—Flutamide—prostate cancer	0.00348	0.00455	CcSEcCtD
Butabarbital—Rash—Nilutamide—prostate cancer	0.00346	0.00453	CcSEcCtD
Butabarbital—Dermatitis—Nilutamide—prostate cancer	0.00346	0.00452	CcSEcCtD
Butabarbital—Rash—Flutamide—prostate cancer	0.00345	0.00451	CcSEcCtD
Butabarbital—Dermatitis—Flutamide—prostate cancer	0.00345	0.0045	CcSEcCtD
Butabarbital—Headache—Nilutamide—prostate cancer	0.00344	0.0045	CcSEcCtD
Butabarbital—Headache—Flutamide—prostate cancer	0.00343	0.00448	CcSEcCtD
Butabarbital—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00341	0.00446	CcSEcCtD
Butabarbital—Hypersensitivity—Cabazitaxel—prostate cancer	0.00341	0.00445	CcSEcCtD
Butabarbital—Constipation—Bicalutamide—prostate cancer	0.00339	0.00443	CcSEcCtD
Butabarbital—Tension—Goserelin—prostate cancer	0.00332	0.00434	CcSEcCtD
Butabarbital—Tension—Conjugated Estrogens—prostate cancer	0.00329	0.0043	CcSEcCtD
Butabarbital—Nervousness—Goserelin—prostate cancer	0.00328	0.00429	CcSEcCtD
Butabarbital—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00328	0.00429	CcSEcCtD
Butabarbital—Feeling abnormal—Bicalutamide—prostate cancer	0.00327	0.00427	CcSEcCtD
Butabarbital—Nausea—Nilutamide—prostate cancer	0.00326	0.00427	CcSEcCtD
Butabarbital—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00326	0.00425	CcSEcCtD
Butabarbital—Nervousness—Conjugated Estrogens—prostate cancer	0.00325	0.00425	CcSEcCtD
Butabarbital—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00325	0.00425	CcSEcCtD
Butabarbital—Nausea—Flutamide—prostate cancer	0.00325	0.00425	CcSEcCtD
Butabarbital—Dizziness—Degarelix—prostate cancer	0.00325	0.00424	CcSEcCtD
Butabarbital—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00323	0.00423	CcSEcCtD
Butabarbital—Liver injury—Epirubicin—prostate cancer	0.00317	0.00414	CcSEcCtD
Butabarbital—Body temperature increased—Bicalutamide—prostate cancer	0.00314	0.0041	CcSEcCtD
Butabarbital—Vomiting—Degarelix—prostate cancer	0.00312	0.00408	CcSEcCtD
Butabarbital—Rash—Degarelix—prostate cancer	0.0031	0.00405	CcSEcCtD
Butabarbital—Dermatitis—Degarelix—prostate cancer	0.00309	0.00404	CcSEcCtD
Butabarbital—Headache—Degarelix—prostate cancer	0.00308	0.00402	CcSEcCtD
Butabarbital—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00307	0.00401	CcSEcCtD
Butabarbital—Angioedema—Conjugated Estrogens—prostate cancer	0.00306	0.004	CcSEcCtD
Butabarbital—Dizziness—Cabazitaxel—prostate cancer	0.00306	0.004	CcSEcCtD
Butabarbital—Syncope—Conjugated Estrogens—prostate cancer	0.003	0.00393	CcSEcCtD
Butabarbital—Hyperkinesia—Prednisone—prostate cancer	0.00297	0.00388	CcSEcCtD
Butabarbital—Loss of consciousness—Conjugated Estrogens—prostate cancer	0.00294	0.00385	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Capecitabine—prostate cancer	0.00294	0.00384	CcSEcCtD
Butabarbital—Vomiting—Cabazitaxel—prostate cancer	0.00294	0.00384	CcSEcCtD
Butabarbital—Liver injury—Doxorubicin—prostate cancer	0.00293	0.00383	CcSEcCtD
Butabarbital—Hypersensitivity—Bicalutamide—prostate cancer	0.00292	0.00382	CcSEcCtD
Butabarbital—Bradycardia—Mitoxantrone—prostate cancer	0.00292	0.00382	CcSEcCtD
Butabarbital—Nausea—Degarelix—prostate cancer	0.00292	0.00381	CcSEcCtD
Butabarbital—Headache—Cabazitaxel—prostate cancer	0.0029	0.00379	CcSEcCtD
Butabarbital—Anxiety—Goserelin—prostate cancer	0.00287	0.00375	CcSEcCtD
Butabarbital—Constipation—Ethinyl Estradiol—prostate cancer	0.00287	0.00375	CcSEcCtD
Butabarbital—Anxiety—Conjugated Estrogens—prostate cancer	0.00284	0.00371	CcSEcCtD
Butabarbital—Confusional state—Goserelin—prostate cancer	0.00278	0.00364	CcSEcCtD
Butabarbital—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.00276	0.00361	CcSEcCtD
Butabarbital—Nausea—Cabazitaxel—prostate cancer	0.00275	0.00359	CcSEcCtD
Butabarbital—Shock—Goserelin—prostate cancer	0.00272	0.00355	CcSEcCtD
Butabarbital—Ataxia—Docetaxel—prostate cancer	0.0027	0.00352	CcSEcCtD
Butabarbital—Shock—Conjugated Estrogens—prostate cancer	0.00269	0.00351	CcSEcCtD
Butabarbital—Hepatocellular injury—Epirubicin—prostate cancer	0.00266	0.00348	CcSEcCtD
Butabarbital—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.00265	0.00346	CcSEcCtD
Butabarbital—Tension—Estradiol—prostate cancer	0.00263	0.00344	CcSEcCtD
Butabarbital—Dizziness—Bicalutamide—prostate cancer	0.00262	0.00343	CcSEcCtD
Butabarbital—Ataxia—Capecitabine—prostate cancer	0.00261	0.00341	CcSEcCtD
Butabarbital—Nervousness—Estradiol—prostate cancer	0.0026	0.0034	CcSEcCtD
Butabarbital—Amobarbital—CYP2A6—prostate cancer	0.00259	0.115	CrCbGaD
Butabarbital—Hypotension—Goserelin—prostate cancer	0.00258	0.00337	CcSEcCtD
Butabarbital—Phenobarbital—CYP2C18—prostate cancer	0.00256	0.114	CrCbGaD
Butabarbital—Hypotension—Conjugated Estrogens—prostate cancer	0.00255	0.00334	CcSEcCtD
Butabarbital—Vomiting—Bicalutamide—prostate cancer	0.00252	0.0033	CcSEcCtD
Butabarbital—Rash—Bicalutamide—prostate cancer	0.0025	0.00327	CcSEcCtD
Butabarbital—Dermatitis—Bicalutamide—prostate cancer	0.0025	0.00327	CcSEcCtD
Butabarbital—Headache—Bicalutamide—prostate cancer	0.00249	0.00325	CcSEcCtD
Butabarbital—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00247	0.00323	CcSEcCtD
Butabarbital—Hepatocellular injury—Doxorubicin—prostate cancer	0.00247	0.00322	CcSEcCtD
Butabarbital—Agitation—Estradiol—prostate cancer	0.00246	0.00322	CcSEcCtD
Butabarbital—Somnolence—Goserelin—prostate cancer	0.00245	0.00321	CcSEcCtD
Butabarbital—Angioedema—Estradiol—prostate cancer	0.00245	0.0032	CcSEcCtD
Butabarbital—Somnolence—Conjugated Estrogens—prostate cancer	0.00243	0.00318	CcSEcCtD
Butabarbital—Syncope—Estradiol—prostate cancer	0.0024	0.00314	CcSEcCtD
Butabarbital—Constipation—Goserelin—prostate cancer	0.00236	0.00308	CcSEcCtD
Butabarbital—Nausea—Bicalutamide—prostate cancer	0.00236	0.00308	CcSEcCtD
Butabarbital—Loss of consciousness—Estradiol—prostate cancer	0.00236	0.00308	CcSEcCtD
Butabarbital—Constipation—Conjugated Estrogens—prostate cancer	0.00234	0.00305	CcSEcCtD
Butabarbital—Anxiety—Estradiol—prostate cancer	0.00227	0.00297	CcSEcCtD
Butabarbital—Feeling abnormal—Goserelin—prostate cancer	0.00227	0.00297	CcSEcCtD
Butabarbital—Dizziness—Ethinyl Estradiol—prostate cancer	0.00222	0.0029	CcSEcCtD
Butabarbital—Confusional state—Estradiol—prostate cancer	0.00221	0.00288	CcSEcCtD
Butabarbital—Body temperature increased—Goserelin—prostate cancer	0.00218	0.00285	CcSEcCtD
Butabarbital—Pentobarbital—CYP2A6—prostate cancer	0.00218	0.0969	CrCbGaD
Butabarbital—Body temperature increased—Conjugated Estrogens—prostate cancer	0.00216	0.00282	CcSEcCtD
Butabarbital—Shock—Estradiol—prostate cancer	0.00215	0.00281	CcSEcCtD
Butabarbital—Vomiting—Ethinyl Estradiol—prostate cancer	0.00213	0.00279	CcSEcCtD
Butabarbital—Anxiety—Mitoxantrone—prostate cancer	0.00212	0.00277	CcSEcCtD
Butabarbital—Phenobarbital—CYP1B1—prostate cancer	0.00212	0.0941	CrCbGaD
Butabarbital—Rash—Ethinyl Estradiol—prostate cancer	0.00211	0.00276	CcSEcCtD
Butabarbital—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00211	0.00276	CcSEcCtD
Butabarbital—Headache—Ethinyl Estradiol—prostate cancer	0.0021	0.00275	CcSEcCtD
Butabarbital—Confusional state—Mitoxantrone—prostate cancer	0.00206	0.00269	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Epirubicin—prostate cancer	0.00205	0.00268	CcSEcCtD
Butabarbital—Hypersensitivity—Goserelin—prostate cancer	0.00203	0.00266	CcSEcCtD
Butabarbital—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.00201	0.00263	CcSEcCtD
Butabarbital—Shock—Mitoxantrone—prostate cancer	0.00201	0.00262	CcSEcCtD
Butabarbital—Nausea—Ethinyl Estradiol—prostate cancer	0.00199	0.0026	CcSEcCtD
Butabarbital—Bradycardia—Capecitabine—prostate cancer	0.00195	0.00255	CcSEcCtD
Butabarbital—Somnolence—Estradiol—prostate cancer	0.00194	0.00254	CcSEcCtD
Butabarbital—Hypotension—Mitoxantrone—prostate cancer	0.0019	0.00249	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Doxorubicin—prostate cancer	0.0019	0.00248	CcSEcCtD
Butabarbital—Constipation—Estradiol—prostate cancer	0.00187	0.00244	CcSEcCtD
Butabarbital—Thiopental—CYP2E1—prostate cancer	0.00186	0.0829	CrCbGaD
Butabarbital—Loss of consciousness—Etoposide—prostate cancer	0.00183	0.00239	CcSEcCtD
Butabarbital—Dizziness—Goserelin—prostate cancer	0.00182	0.00238	CcSEcCtD
Butabarbital—Ataxia—Epirubicin—prostate cancer	0.00182	0.00238	CcSEcCtD
Butabarbital—Somnolence—Mitoxantrone—prostate cancer	0.00181	0.00237	CcSEcCtD
Butabarbital—Dizziness—Conjugated Estrogens—prostate cancer	0.00181	0.00236	CcSEcCtD
Butabarbital—Feeling abnormal—Estradiol—prostate cancer	0.0018	0.00236	CcSEcCtD
Butabarbital—Vomiting—Goserelin—prostate cancer	0.00175	0.00229	CcSEcCtD
Butabarbital—Constipation—Mitoxantrone—prostate cancer	0.00174	0.00228	CcSEcCtD
Butabarbital—Bradycardia—Prednisone—prostate cancer	0.00174	0.00228	CcSEcCtD
Butabarbital—Rash—Goserelin—prostate cancer	0.00174	0.00227	CcSEcCtD
Butabarbital—Dermatitis—Goserelin—prostate cancer	0.00174	0.00227	CcSEcCtD
Butabarbital—Vomiting—Conjugated Estrogens—prostate cancer	0.00174	0.00227	CcSEcCtD
Butabarbital—Body temperature increased—Estradiol—prostate cancer	0.00173	0.00226	CcSEcCtD
Butabarbital—Headache—Goserelin—prostate cancer	0.00173	0.00226	CcSEcCtD
Butabarbital—Rash—Conjugated Estrogens—prostate cancer	0.00172	0.00225	CcSEcCtD
Butabarbital—Dermatitis—Conjugated Estrogens—prostate cancer	0.00172	0.00225	CcSEcCtD
Butabarbital—Headache—Conjugated Estrogens—prostate cancer	0.00171	0.00224	CcSEcCtD
Butabarbital—Confusional state—Etoposide—prostate cancer	0.00171	0.00223	CcSEcCtD
Butabarbital—Hallucination—Prednisone—prostate cancer	0.0017	0.00222	CcSEcCtD
Butabarbital—Phenobarbital—CYP3A5—prostate cancer	0.00168	0.075	CrCbGaD
Butabarbital—Ataxia—Doxorubicin—prostate cancer	0.00168	0.0022	CcSEcCtD
Butabarbital—Feeling abnormal—Mitoxantrone—prostate cancer	0.00168	0.0022	CcSEcCtD
Butabarbital—Nausea—Goserelin—prostate cancer	0.00164	0.00214	CcSEcCtD
Butabarbital—Phenobarbital—CYP2A6—prostate cancer	0.00163	0.0726	CrCbGaD
Butabarbital—Nausea—Conjugated Estrogens—prostate cancer	0.00162	0.00212	CcSEcCtD
Butabarbital—Hypersensitivity—Estradiol—prostate cancer	0.00161	0.00211	CcSEcCtD
Butabarbital—Body temperature increased—Mitoxantrone—prostate cancer	0.00161	0.00211	CcSEcCtD
Butabarbital—Hypotension—Etoposide—prostate cancer	0.00158	0.00207	CcSEcCtD
Butabarbital—Syncope—Docetaxel—prostate cancer	0.00155	0.00202	CcSEcCtD
Butabarbital—Pentobarbital—CYP2C19—prostate cancer	0.00153	0.0681	CrCbGaD
Butabarbital—Loss of consciousness—Docetaxel—prostate cancer	0.00152	0.00198	CcSEcCtD
Butabarbital—Somnolence—Etoposide—prostate cancer	0.00151	0.00197	CcSEcCtD
Butabarbital—Hypersensitivity—Mitoxantrone—prostate cancer	0.0015	0.00196	CcSEcCtD
Butabarbital—Syncope—Capecitabine—prostate cancer	0.0015	0.00196	CcSEcCtD
Butabarbital—Loss of consciousness—Capecitabine—prostate cancer	0.00147	0.00192	CcSEcCtD
Butabarbital—Constipation—Etoposide—prostate cancer	0.00145	0.00189	CcSEcCtD
Butabarbital—Dizziness—Estradiol—prostate cancer	0.00145	0.00189	CcSEcCtD
Butabarbital—Confusional state—Docetaxel—prostate cancer	0.00142	0.00186	CcSEcCtD
Butabarbital—Anxiety—Capecitabine—prostate cancer	0.00142	0.00185	CcSEcCtD
Butabarbital—Feeling abnormal—Etoposide—prostate cancer	0.0014	0.00183	CcSEcCtD
Butabarbital—Vomiting—Estradiol—prostate cancer	0.00139	0.00182	CcSEcCtD
Butabarbital—Shock—Docetaxel—prostate cancer	0.00139	0.00181	CcSEcCtD
Butabarbital—Rash—Estradiol—prostate cancer	0.00138	0.0018	CcSEcCtD
Butabarbital—Dermatitis—Estradiol—prostate cancer	0.00138	0.0018	CcSEcCtD
Butabarbital—Confusional state—Capecitabine—prostate cancer	0.00138	0.0018	CcSEcCtD
Butabarbital—Headache—Estradiol—prostate cancer	0.00137	0.00179	CcSEcCtD
Butabarbital—Agitation—Prednisone—prostate cancer	0.00137	0.00179	CcSEcCtD
Butabarbital—Bradycardia—Epirubicin—prostate cancer	0.00136	0.00178	CcSEcCtD
Butabarbital—Angioedema—Prednisone—prostate cancer	0.00136	0.00178	CcSEcCtD
Butabarbital—Shock—Capecitabine—prostate cancer	0.00134	0.00175	CcSEcCtD
Butabarbital—Body temperature increased—Etoposide—prostate cancer	0.00134	0.00175	CcSEcCtD
Butabarbital—Syncope—Prednisone—prostate cancer	0.00134	0.00175	CcSEcCtD
Butabarbital—Hypotension—Docetaxel—prostate cancer	0.00132	0.00172	CcSEcCtD
Butabarbital—Loss of consciousness—Prednisone—prostate cancer	0.00131	0.00171	CcSEcCtD
Butabarbital—Nausea—Estradiol—prostate cancer	0.0013	0.0017	CcSEcCtD
Butabarbital—Vomiting—Mitoxantrone—prostate cancer	0.0013	0.00169	CcSEcCtD
Butabarbital—Rash—Mitoxantrone—prostate cancer	0.00129	0.00168	CcSEcCtD
Butabarbital—Dermatitis—Mitoxantrone—prostate cancer	0.00128	0.00168	CcSEcCtD
Butabarbital—Headache—Mitoxantrone—prostate cancer	0.00128	0.00167	CcSEcCtD
Butabarbital—Hypotension—Capecitabine—prostate cancer	0.00127	0.00167	CcSEcCtD
Butabarbital—Anxiety—Prednisone—prostate cancer	0.00126	0.00165	CcSEcCtD
Butabarbital—Bradycardia—Doxorubicin—prostate cancer	0.00126	0.00165	CcSEcCtD
Butabarbital—Somnolence—Docetaxel—prostate cancer	0.00125	0.00164	CcSEcCtD
Butabarbital—Hypersensitivity—Etoposide—prostate cancer	0.00125	0.00163	CcSEcCtD
Butabarbital—Nausea—Mitoxantrone—prostate cancer	0.00121	0.00158	CcSEcCtD
Butabarbital—Constipation—Docetaxel—prostate cancer	0.00121	0.00157	CcSEcCtD
Butabarbital—Shock—Prednisone—prostate cancer	0.0012	0.00156	CcSEcCtD
Butabarbital—Thiopental—CYP3A4—prostate cancer	0.00117	0.0522	CrCbGaD
Butabarbital—Constipation—Capecitabine—prostate cancer	0.00117	0.00152	CcSEcCtD
Butabarbital—Feeling abnormal—Docetaxel—prostate cancer	0.00116	0.00152	CcSEcCtD
Butabarbital—Phenobarbital—CYP2E1—prostate cancer	0.00116	0.0515	CrCbGaD
Butabarbital—Phenobarbital—CYP2C19—prostate cancer	0.00115	0.051	CrCbGaD
Butabarbital—Tension—Epirubicin—prostate cancer	0.00114	0.00149	CcSEcCtD
Butabarbital—Phenobarbital—CYP1A1—prostate cancer	0.00114	0.0508	CrCbGaD
Butabarbital—Nervousness—Epirubicin—prostate cancer	0.00113	0.00148	CcSEcCtD
Butabarbital—Feeling abnormal—Capecitabine—prostate cancer	0.00112	0.00147	CcSEcCtD
Butabarbital—Dizziness—Etoposide—prostate cancer	0.00112	0.00147	CcSEcCtD
Butabarbital—Body temperature increased—Docetaxel—prostate cancer	0.00111	0.00146	CcSEcCtD
Butabarbital—Body temperature increased—Capecitabine—prostate cancer	0.00108	0.00141	CcSEcCtD
Butabarbital—Vomiting—Etoposide—prostate cancer	0.00108	0.00141	CcSEcCtD
Butabarbital—Agitation—Epirubicin—prostate cancer	0.00107	0.0014	CcSEcCtD
Butabarbital—Rash—Etoposide—prostate cancer	0.00107	0.0014	CcSEcCtD
Butabarbital—Dermatitis—Etoposide—prostate cancer	0.00107	0.0014	CcSEcCtD
Butabarbital—Headache—Etoposide—prostate cancer	0.00106	0.00139	CcSEcCtD
Butabarbital—Tension—Doxorubicin—prostate cancer	0.00106	0.00138	CcSEcCtD
Butabarbital—Nervousness—Doxorubicin—prostate cancer	0.00105	0.00137	CcSEcCtD
Butabarbital—Syncope—Epirubicin—prostate cancer	0.00104	0.00136	CcSEcCtD
Butabarbital—Constipation—Prednisone—prostate cancer	0.00104	0.00136	CcSEcCtD
Butabarbital—Hypersensitivity—Docetaxel—prostate cancer	0.00104	0.00136	CcSEcCtD
Butabarbital—Loss of consciousness—Epirubicin—prostate cancer	0.00102	0.00134	CcSEcCtD
Butabarbital—Nausea—Etoposide—prostate cancer	0.00101	0.00132	CcSEcCtD
Butabarbital—Hypersensitivity—Capecitabine—prostate cancer	0.00101	0.00131	CcSEcCtD
Butabarbital—Feeling abnormal—Prednisone—prostate cancer	0.001	0.00131	CcSEcCtD
Butabarbital—Agitation—Doxorubicin—prostate cancer	0.00099	0.00129	CcSEcCtD
Butabarbital—Anxiety—Epirubicin—prostate cancer	0.000988	0.00129	CcSEcCtD
Butabarbital—Pentobarbital—CYP3A4—prostate cancer	0.000973	0.0433	CrCbGaD
Butabarbital—Syncope—Doxorubicin—prostate cancer	0.000966	0.00126	CcSEcCtD
Butabarbital—Body temperature increased—Prednisone—prostate cancer	0.000961	0.00126	CcSEcCtD
Butabarbital—Confusional state—Epirubicin—prostate cancer	0.000958	0.00125	CcSEcCtD
Butabarbital—Loss of consciousness—Doxorubicin—prostate cancer	0.000947	0.00124	CcSEcCtD
Butabarbital—Shock—Epirubicin—prostate cancer	0.000935	0.00122	CcSEcCtD
Butabarbital—Dizziness—Docetaxel—prostate cancer	0.000932	0.00122	CcSEcCtD
Butabarbital—Anxiety—Doxorubicin—prostate cancer	0.000914	0.00119	CcSEcCtD
Butabarbital—Dizziness—Capecitabine—prostate cancer	0.000902	0.00118	CcSEcCtD
Butabarbital—Vomiting—Docetaxel—prostate cancer	0.000896	0.00117	CcSEcCtD
Butabarbital—Hypersensitivity—Prednisone—prostate cancer	0.000895	0.00117	CcSEcCtD
Butabarbital—GRIK2—Transmission across Chemical Synapses—ACHE—prostate cancer	0.000889	0.00419	CbGpPWpGaD
Butabarbital—Rash—Docetaxel—prostate cancer	0.000888	0.00116	CcSEcCtD
Butabarbital—Hypotension—Epirubicin—prostate cancer	0.000888	0.00116	CcSEcCtD
Butabarbital—Dermatitis—Docetaxel—prostate cancer	0.000888	0.00116	CcSEcCtD
Butabarbital—Confusional state—Doxorubicin—prostate cancer	0.000887	0.00116	CcSEcCtD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RRAS—prostate cancer	0.000886	0.00417	CbGpPWpGaD
Butabarbital—Headache—Docetaxel—prostate cancer	0.000883	0.00115	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL1RN—prostate cancer	0.000878	0.00413	CbGpPWpGaD
Butabarbital—Vomiting—Capecitabine—prostate cancer	0.000867	0.00113	CcSEcCtD
Butabarbital—Shock—Doxorubicin—prostate cancer	0.000865	0.00113	CcSEcCtD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACB—prostate cancer	0.000865	0.00407	CbGpPWpGaD
Butabarbital—GRIA2—N-cadherin signaling events—CTNNB1—prostate cancer	0.000861	0.00405	CbGpPWpGaD
Butabarbital—Rash—Capecitabine—prostate cancer	0.00086	0.00112	CcSEcCtD
Butabarbital—Dermatitis—Capecitabine—prostate cancer	0.000859	0.00112	CcSEcCtD
Butabarbital—Headache—Capecitabine—prostate cancer	0.000855	0.00112	CcSEcCtD
Butabarbital—GRIK2—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.00085	0.004	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—RRAS—prostate cancer	0.00085	0.004	CbGpPWpGaD
Butabarbital—Somnolence—Epirubicin—prostate cancer	0.000845	0.0011	CcSEcCtD
Butabarbital—GRIK2—Neuronal System—PLCB2—prostate cancer	0.000842	0.00396	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—PLCB2—prostate cancer	0.00084	0.00396	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB2—prostate cancer	0.00084	0.00395	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACB—prostate cancer	0.000839	0.00395	CbGpPWpGaD
Butabarbital—Nausea—Docetaxel—prostate cancer	0.000837	0.00109	CcSEcCtD
Butabarbital—GABRB2—Transmission across Chemical Synapses—RRAS—prostate cancer	0.000833	0.00392	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—KCNN3—prostate cancer	0.000826	0.00389	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—RRAS—prostate cancer	0.000824	0.00388	CbGpPWpGaD
Butabarbital—Hypotension—Doxorubicin—prostate cancer	0.000822	0.00107	CcSEcCtD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—PLCB2—prostate cancer	0.000815	0.00384	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—ESR2—prostate cancer	0.000814	0.00383	CbGpPWpGaD
Butabarbital—Constipation—Epirubicin—prostate cancer	0.000813	0.00106	CcSEcCtD
Butabarbital—Nausea—Capecitabine—prostate cancer	0.00081	0.00106	CcSEcCtD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—ACHE—prostate cancer	0.000809	0.00381	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—TH—prostate cancer	0.000808	0.0038	CbGpPWpGaD
Butabarbital—Dizziness—Prednisone—prostate cancer	0.000804	0.00105	CcSEcCtD
Butabarbital—GRIK2—Neuronal System—SLC22A1—prostate cancer	0.000803	0.00378	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—SLC22A1—prostate cancer	0.000802	0.00377	CbGpPWpGaD
Butabarbital—Feeling abnormal—Epirubicin—prostate cancer	0.000783	0.00102	CcSEcCtD
Butabarbital—Somnolence—Doxorubicin—prostate cancer	0.000782	0.00102	CcSEcCtD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—SLC22A1—prostate cancer	0.000777	0.00366	CbGpPWpGaD
Butabarbital—GABRB2—Orphan transporters—NCOA2—prostate cancer	0.000777	0.00366	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.000773	0.00364	CbGpPWpGaD
Butabarbital—Vomiting—Prednisone—prostate cancer	0.000773	0.00101	CcSEcCtD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—PRKACB—prostate cancer	0.000769	0.00362	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB2—prostate cancer	0.000768	0.00362	CbGpPWpGaD
Butabarbital—Rash—Prednisone—prostate cancer	0.000766	0.001	CcSEcCtD
Butabarbital—CHRNA7—Neuronal System—PLCB2—prostate cancer	0.000766	0.00361	CbGpPWpGaD
Butabarbital—Dermatitis—Prednisone—prostate cancer	0.000766	0.001	CcSEcCtD
Butabarbital—GRIK2—Neuronal System—GNG5—prostate cancer	0.000764	0.0036	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—GNG5—prostate cancer	0.000762	0.00359	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG5—prostate cancer	0.000762	0.00359	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—RRAS—prostate cancer	0.000762	0.00359	CbGpPWpGaD
Butabarbital—Headache—Prednisone—prostate cancer	0.000761	0.000995	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—EGR1—prostate cancer	0.000761	0.00358	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—HSP90B1—prostate cancer	0.000755	0.00356	CbGpPWpGaD
Butabarbital—Constipation—Doxorubicin—prostate cancer	0.000752	0.000983	CcSEcCtD
Butabarbital—Body temperature increased—Epirubicin—prostate cancer	0.000751	0.000982	CcSEcCtD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—GNG5—prostate cancer	0.000739	0.00348	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—SLC22A1—prostate cancer	0.000731	0.00344	CbGpPWpGaD
Butabarbital—Phenobarbital—CYP3A4—prostate cancer	0.000729	0.0325	CrCbGaD
Butabarbital—Feeling abnormal—Doxorubicin—prostate cancer	0.000725	0.000947	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—GJA1—prostate cancer	0.000725	0.00341	CbGpPWpGaD
Butabarbital—Nausea—Prednisone—prostate cancer	0.000722	0.000943	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—AR—prostate cancer	0.000719	0.00338	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL1RN—prostate cancer	0.000716	0.00337	CbGpPWpGaD
Butabarbital—GABRG2—Orphan transporters—NCOA2—prostate cancer	0.000711	0.00335	CbGpPWpGaD
Butabarbital—Hypersensitivity—Epirubicin—prostate cancer	0.0007	0.000915	CcSEcCtD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG5—prostate cancer	0.000697	0.00328	CbGpPWpGaD
Butabarbital—Body temperature increased—Doxorubicin—prostate cancer	0.000695	0.000909	CcSEcCtD
Butabarbital—CHRNA7—Neuronal System—GNG5—prostate cancer	0.000695	0.00327	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—EGR1—prostate cancer	0.000682	0.00321	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—ACHE—prostate cancer	0.000681	0.00321	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—ACHE—prostate cancer	0.00068	0.0032	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—NGFR—prostate cancer	0.000678	0.00319	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB2—prostate cancer	0.000671	0.00316	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—RRAS—prostate cancer	0.000666	0.00314	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—ESR2—prostate cancer	0.000663	0.00312	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—ACHE—prostate cancer	0.000659	0.0031	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—TH—prostate cancer	0.000659	0.0031	CbGpPWpGaD
Butabarbital—GABRB2—Orphan transporters—NCOA1—prostate cancer	0.000655	0.00308	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—PRKACB—prostate cancer	0.000651	0.00307	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.00065	0.00306	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACB—prostate cancer	0.000649	0.00306	CbGpPWpGaD
Butabarbital—Hypersensitivity—Doxorubicin—prostate cancer	0.000648	0.000847	CcSEcCtD
Butabarbital—GRIA2—Neuronal System—PLCB2—prostate cancer	0.000644	0.00303	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—RRAS—prostate cancer	0.000638	0.003	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—PLCB2—prostate cancer	0.000631	0.00297	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.00063	0.00297	CbGpPWpGaD
Butabarbital—Dizziness—Epirubicin—prostate cancer	0.000629	0.000821	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—prostate cancer	0.000628	0.00296	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—PLCB2—prostate cancer	0.000624	0.00294	CbGpPWpGaD
Butabarbital—GABRB2—Orphan transporters—RXRA—prostate cancer	0.000623	0.00293	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—VAV3—prostate cancer	0.000621	0.00293	CbGpPWpGaD
Butabarbital—GABRA1—Orphan transporters—NCOA2—prostate cancer	0.000621	0.00292	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—EGR1—prostate cancer	0.00062	0.00292	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—ACHE—prostate cancer	0.000619	0.00292	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—COMT—prostate cancer	0.000619	0.00291	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—SLC22A1—prostate cancer	0.000614	0.00289	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG5—prostate cancer	0.000609	0.00287	CbGpPWpGaD
Butabarbital—Vomiting—Epirubicin—prostate cancer	0.000604	0.00079	CcSEcCtD
Butabarbital—GABRB2—Transmission across Chemical Synapses—SLC22A1—prostate cancer	0.000602	0.00284	CbGpPWpGaD
Butabarbital—Rash—Epirubicin—prostate cancer	0.000599	0.000783	CcSEcCtD
Butabarbital—Dermatitis—Epirubicin—prostate cancer	0.000599	0.000782	CcSEcCtD
Butabarbital—GABRG2—Orphan transporters—NCOA1—prostate cancer	0.000599	0.00282	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000597	0.00281	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—SLC22A1—prostate cancer	0.000596	0.00281	CbGpPWpGaD
Butabarbital—Headache—Epirubicin—prostate cancer	0.000595	0.000778	CcSEcCtD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACB—prostate cancer	0.000594	0.0028	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—PRKACB—prostate cancer	0.000593	0.00279	CbGpPWpGaD
Butabarbital—GRIA2—N-cadherin signaling events—PIK3CA—prostate cancer	0.000592	0.00279	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—GJA1—prostate cancer	0.000591	0.00278	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—AR—prostate cancer	0.000586	0.00276	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—GNG5—prostate cancer	0.000584	0.00275	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—RRAS—prostate cancer	0.000584	0.00275	CbGpPWpGaD
Butabarbital—Dizziness—Doxorubicin—prostate cancer	0.000582	0.00076	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.000581	0.00274	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—PLCB2—prostate cancer	0.000577	0.00272	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—GNG5—prostate cancer	0.000573	0.0027	CbGpPWpGaD
Butabarbital—GABRG2—Orphan transporters—RXRA—prostate cancer	0.000569	0.00268	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—GNG5—prostate cancer	0.000567	0.00267	CbGpPWpGaD
Butabarbital—Nausea—Epirubicin—prostate cancer	0.000565	0.000738	CcSEcCtD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—COMT—prostate cancer	0.000563	0.00265	CbGpPWpGaD
Butabarbital—Vomiting—Doxorubicin—prostate cancer	0.000559	0.000731	CcSEcCtD
Butabarbital—Rash—Doxorubicin—prostate cancer	0.000555	0.000725	CcSEcCtD
Butabarbital—Dermatitis—Doxorubicin—prostate cancer	0.000554	0.000724	CcSEcCtD
Butabarbital—Headache—Doxorubicin—prostate cancer	0.000551	0.00072	CcSEcCtD
Butabarbital—GABRG2—Transmission across Chemical Synapses—SLC22A1—prostate cancer	0.000551	0.00259	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000546	0.00257	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.00053	0.00249	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—GNG5—prostate cancer	0.000524	0.00247	CbGpPWpGaD
Butabarbital—GABRA1—Orphan transporters—NCOA1—prostate cancer	0.000523	0.00246	CbGpPWpGaD
Butabarbital—Nausea—Doxorubicin—prostate cancer	0.000522	0.000683	CcSEcCtD
Butabarbital—GRIA2—Neuronal System—ACHE—prostate cancer	0.000521	0.00245	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACB—prostate cancer	0.000519	0.00244	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—prostate cancer	0.000512	0.00241	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—ACHE—prostate cancer	0.00051	0.0024	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—RRAS—prostate cancer	0.00051	0.0024	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—ACHE—prostate cancer	0.000505	0.00238	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—PLCB2—prostate cancer	0.000505	0.00238	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—PRKACB—prostate cancer	0.000498	0.00235	CbGpPWpGaD
Butabarbital—GABRA1—Orphan transporters—RXRA—prostate cancer	0.000498	0.00234	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.000488	0.0023	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—PLCB2—prostate cancer	0.000484	0.00228	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—PRKACB—prostate cancer	0.000483	0.00227	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—SLC22A1—prostate cancer	0.000481	0.00227	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000477	0.00225	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—PRKACB—prostate cancer	0.000476	0.00224	CbGpPWpGaD
Butabarbital—GABRB2—Orphan transporters—PPARA—prostate cancer	0.000476	0.00224	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—COMT—prostate cancer	0.000474	0.00223	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.000474	0.00223	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—COMT—prostate cancer	0.000473	0.00223	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000472	0.00222	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—ACHE—prostate cancer	0.000467	0.0022	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—SLC22A1—prostate cancer	0.000461	0.00217	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—COMT—prostate cancer	0.000459	0.00216	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—GNG5—prostate cancer	0.000458	0.00216	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.000447	0.0021	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL1RN—prostate cancer	0.000443	0.00209	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—PLCB2—prostate cancer	0.000442	0.00208	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.00044	0.00207	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—GNG5—prostate cancer	0.000439	0.00207	CbGpPWpGaD
Butabarbital—GABRG2—Orphan transporters—PPARA—prostate cancer	0.000435	0.00205	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.000433	0.00204	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000432	0.00203	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.000432	0.00203	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—BAD—prostate cancer	0.000432	0.00203	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—COMT—prostate cancer	0.000431	0.00203	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—SLC22A1—prostate cancer	0.000422	0.00199	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—APC—prostate cancer	0.000418	0.00197	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—IRS1—prostate cancer	0.000413	0.00195	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—ESR2—prostate cancer	0.000411	0.00193	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—ACHE—prostate cancer	0.000408	0.00192	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—TH—prostate cancer	0.000408	0.00192	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—GNG5—prostate cancer	0.000401	0.00189	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—GSK3B—prostate cancer	0.000401	0.00189	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000401	0.00189	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—ACHE—prostate cancer	0.000391	0.00184	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.00039	0.00184	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—PLCB2—prostate cancer	0.000387	0.00182	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000385	0.00181	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—EGR1—prostate cancer	0.000384	0.00181	CbGpPWpGaD
Butabarbital—GABRA1—Orphan transporters—PPARA—prostate cancer	0.00038	0.00179	CbGpPWpGaD
Butabarbital—GABRB2—Orphan transporters—CREBBP—prostate cancer	0.000378	0.00178	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000377	0.00178	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000375	0.00177	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000375	0.00177	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—PRKACB—prostate cancer	0.000374	0.00176	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—MAP2K1—prostate cancer	0.00037	0.00174	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—SLC22A1—prostate cancer	0.000369	0.00174	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—GJA1—prostate cancer	0.000366	0.00172	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—AR—prostate cancer	0.000363	0.00171	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—COMT—prostate cancer	0.000363	0.00171	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—ACHE—prostate cancer	0.000358	0.00168	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—COMT—prostate cancer	0.000355	0.00167	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.000353	0.00166	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000352	0.00166	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—COMT—prostate cancer	0.000352	0.00166	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—GNG5—prostate cancer	0.000351	0.00165	CbGpPWpGaD
Butabarbital—GABRG2—Orphan transporters—CREBBP—prostate cancer	0.000345	0.00163	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.000343	0.00162	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000343	0.00162	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000343	0.00162	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—PRKACB—prostate cancer	0.000342	0.00161	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—JAK2—prostate cancer	0.000337	0.00159	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000337	0.00159	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000331	0.00156	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000329	0.00155	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000327	0.00154	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—COMT—prostate cancer	0.000325	0.00153	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL10—prostate cancer	0.000317	0.00149	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000317	0.00149	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—ACHE—prostate cancer	0.000313	0.00147	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000308	0.00145	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000304	0.00143	CbGpPWpGaD
Butabarbital—GABRA1—Orphan transporters—CREBBP—prostate cancer	0.000302	0.00142	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000301	0.00142	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.0003	0.00141	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.0003	0.00141	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—PRKACB—prostate cancer	0.000299	0.00141	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—CASP3—prostate cancer	0.000295	0.00139	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000295	0.00139	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.000293	0.00138	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—COMT—prostate cancer	0.000284	0.00134	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—CTNNB1—prostate cancer	0.000284	0.00134	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000281	0.00132	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.00028	0.00132	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000279	0.00131	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000278	0.00131	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—COMT—prostate cancer	0.000272	0.00128	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000268	0.00126	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.000267	0.00126	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000258	0.00122	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000257	0.00121	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—SRC—prostate cancer	0.000257	0.00121	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—MDM2—prostate cancer	0.000254	0.00119	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000253	0.00119	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000253	0.00119	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—COMT—prostate cancer	0.000249	0.00117	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000248	0.00117	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—STAT3—prostate cancer	0.000248	0.00117	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000246	0.00116	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000243	0.00115	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—EP300—prostate cancer	0.00024	0.00113	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000236	0.00111	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000231	0.00109	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—MDM2—prostate cancer	0.000231	0.00109	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000227	0.00107	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000227	0.00107	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000224	0.00106	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.000218	0.00103	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—COMT—prostate cancer	0.000218	0.00103	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000216	0.00102	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000202	0.000952	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000201	0.000947	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000198	0.000934	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—MDM2—prostate cancer	0.000194	0.000913	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000193	0.000909	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—MDM2—prostate cancer	0.00019	0.000895	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.00019	0.000893	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000189	0.000888	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—MDM2—prostate cancer	0.000188	0.000886	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000184	0.000866	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000181	0.000852	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000174	0.000819	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000173	0.000817	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.000173	0.000816	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000166	0.000781	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000165	0.000779	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000161	0.000757	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.00016	0.000753	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.00016	0.000753	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—AKT1—prostate cancer	0.00016	0.000751	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000157	0.000741	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000152	0.000716	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000152	0.000716	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000152	0.000714	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000149	0.0007	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000146	0.000688	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—MDM2—prostate cancer	0.000146	0.000686	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000145	0.000681	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000141	0.000663	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000139	0.000655	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—MDM2—prostate cancer	0.000133	0.000627	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000128	0.000602	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000122	0.000572	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—MDM2—prostate cancer	0.000116	0.000548	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000116	0.000547	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000106	0.0005	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL6—prostate cancer	9.74e-05	0.000459	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—PPARA—prostate cancer	9.28e-05	0.000437	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—CREBBP—prostate cancer	9.22e-05	0.000434	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	8.43e-05	0.000397	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	7.37e-05	0.000347	CbGpPWpGaD
